Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone before TULP for ureteral stone treatment
IRCT20170417033489N10Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dexamethasone in ureterolithiasis and nephrolithiasis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Stone availability during ureteroscopy, Operation length and 1 more. Started Feb 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
ureterolithiasisnephrolithiasis
Beyond the preview
Go deeper on IRCT20170417033489N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170417033489N10.